Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
VF Corp
VFC
$7.16B
| $15.2M | 0.02% |
+218,772
| New | +$14.5M |
|
1127
First Interstate BancSystem
FIBK
$3.7B
| $15.2M | 0.02% |
380,519
-109,000
| -22% | -$4.23M |
|
1128
Manhattan Associates
MANH
$9.95B
| $15.2M | 0.02% |
306,760
-1,002,900
| -77% | -$45M |
|
1129
Wolfspeed
WOLF
$1.14B
| $15.2M | 0.02% |
408,942
+329,400
| +414% | +$11.4M |
|
|
BSMX
1130
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $15.2M | 0.02% |
2,077,626
+336,326
| +19% | +$2.81M |
|
|
BKI
1131
DELISTED
Black Knight, Inc. Common Stock
BKI
| $15.2M | 0.02% |
343,975
+98,675
| +40% | +$4.46M |
|
1132
Estee Lauder
EL
$30.7B
| $15.2M | 0.02% |
119,300
-366,900
| -75% | -$44.1M |
|
|
JMEI
1133
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $15.2M | 0.02% |
518,850
+35,940
| +7% | +$1.06M |
|
1134
ICICI Bank
IBN
$109B
| $15.1M | 0.02% |
1,554,850
-2,668,700
| -63% | -$24.6M |
|
1135
Ennis
EBF
$554M
| $15.1M | 0.02% |
729,000
+12,200
| +2% | +$244K |
|
1136
Prestige Consumer Healthcare
PBH
$2.45B
| $15.1M | 0.02% |
340,000
+189,100
| +125% | +$8.61M |
|
|
CTWS
1137
DELISTED
Connecticut Water Service Inc
CTWS
| $15.1M | 0.02% |
263,000
+22,600
| +9% | +$1.38M |
|
1138
CytomX Therapeutics
CTMX
$701M
| $15.1M | 0.02% |
715,100
+177,200
| +33% | +$3.67M |
|
1139
ANI Pharmaceuticals
ANIP
$1.84B
| $15M | 0.02% |
233,300
-57,000
| -20% | -$3.55M |
|
|
WIN
1140
DELISTED
Windstream Holdings Inc
WIN
| $15M | 0.02% |
1,623,567
-283,580
| -15% | -$2.9M |
|
|
OSB
1141
DELISTED
Norbord Inc.
OSB
| $15M | 0.02% |
442,400
+342,500
| +343% | +$12.3M |
|
1142
Brink's
BCO
$4.87B
| $15M | 0.02% |
190,100
-92,790
| -33% | -$7.51M |
|
1143
Hooker Furnishings Corp
HOFT
$150M
| $14.9M | 0.02% |
351,665
-42,000
| -11% | -$1.96M |
|
1144
Halozyme
HALO
$9.9B
| $14.9M | 0.02% |
+736,600
| New | +$13.5M |
|
1145
CBIZ
CBZ
$2.51B
| $14.9M | 0.02% |
963,807
+91,381
| +10% | +$1.44M |
|
|
CADE
1146
DELISTED
Cadence Bancorporation
CADE
| $14.9M | 0.02% |
+548,900
| New | +$13.2M |
|
1147
Matthews International
MATW
$900M
| $14.9M | 0.02% |
281,650
+180,297
| +178% | +$10.5M |
|
1148
Cedar Fair
FUN
$1.91B
| $14.9M | 0.02% |
+228,735
| New | +$15M |
|
1149
Hamilton Lane
HLNE
$3.91B
| $14.8M | 0.02% |
419,400
+161,300
| +62% | +$4.97M |
|
1150
Realty Income
O
$61.3B
| $14.8M | 0.02% |
268,288
+161,579
| +151% | +$8.77M |
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.